National Center for Complementary & Integrative Health; Notice of Closed Meeting, 113-114 [2024-31477]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Notices
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Contact Person: Nina Sidorova, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Bethesda, MD
20892, 301–594–3663, sidorova@
nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIH Pathway to
Independence Award (K99/R00)
Applications.
Date: March 3–4, 2025.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, MD 20892, 301–594–2886,
tracy.koretsky@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Support for Research
Excellence (SuRE) Program and Support for
Research Excellence—First Independent
Research (SuRE-First) Award (R16).
Date: March 13–14, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Marcienne Michele
Wright, Ph.D., Scientific Review Officer,
National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Bethesda, MD
20892, (301) 827–7635, marci.wright@
nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of IDeA Clinical and
Translational Research Development (CTR–
D) Award and IDeA Clinical and
Translational Research Network (CTR–N)
Award programs.
Date: March 13, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:23 Dec 31, 2024
Jkt 265001
Dated: December 26, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–31448 Filed 12–31–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Advancing Technologies to Improve Delivery
of Pharmacological, Gene Editing, and other
Cargoes for HIV and SUD Mechanistic or
Therapeutic Research.
Date: February 20, 2025.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Division of Extramural Research, Scientific
Review Branch, National Institute on Drug
Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 827–
5702, sindhu.kizhakkemadathil@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group; Career
Development Education and Training Study
Section.
Date: February 28, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
113
Address: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Division of Extramural Research, Scientific
Review Branch, National Institute on Drug
Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 827–
5702, sindhu.kizhakkemadathil@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: December 26, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–31446 Filed 12–31–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Institutional
Research Training Grants (IT).
Date: January 21, 2025.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative, Democracy
II, 6707 Democracy Blvd., Bethesda, MD
20892.
Meeting Format: Virtual Meeting.
Contact Person: Michael E Authement,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, 6707 Democracy Boulevard,
Bethesda, MD 20817, michael.authement@
nih.gov.
E:\FR\FM\02JAN1.SGM
02JAN1
114
Federal Register / Vol. 90, No. 1 / Thursday, January 2, 2025 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 27, 2024.
David W Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Exploratory Clinical
Trials of Mind and Body Interventions (MB).
Date: February 27–28, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative, Democracy
II, 6707 Democracy Blvd., Bethesda, MD
20892.
Meeting Format: Virtual Meeting.
Contact Person: BAILA S Hall, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Blvd., Suite
401, Bethesda, MD 20892, (301) 443–9285,
baila.hall@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
[FR Doc. 2024–31478 Filed 12–31–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:23 Dec 31, 2024
Jkt 265001
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
[FR Doc. 2024–31477 Filed 12–31–24; 8:45 am]
Dated: December 27, 2024.
David W Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Hepatobiliary Pathobiology.
Date: January 22, 2025.
Time: 2:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 26, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–31447 Filed 12–31–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[Docket No. FWS–R7–ES–2024–0128;
FXES111607MRG01–245–FF07CAMM00]
Marine Mammal Protection Act; Draft
Revised Stock Assessment Reports for
Two Stocks of Polar Bears in Alaska
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability; request
for comments.
AGENCY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
In accordance with the
Marine Mammal Protection Act of 1972,
as amended, and its implementing
regulations, we, the U.S. Fish and
Wildlife Service (FWS), have developed
draft revised marine mammal stock
assessment reports (SARs) for the
Chukchi/Bering Seas and Southern
Beaufort Sea polar bear (Ursus
maritimus) stocks in Alaska. We invite
comments on the two draft revised
SARs from the public and from Federal,
Tribal, State, and local governments.
DATES: We must receive comments by
April 2, 2025. Comments submitted
electronically using the Federal
eRulemaking Portal (see ADDRESSES,
below) must be received by 11:59 p.m.
Eastern Time on the closing date.
ADDRESSES:
Obtaining Documents: You may view
the draft revised stock assessment
reports at https://www.regulations.gov
under Docket No. FWS–R7–ES–2024–
0128, or you may request copies from
the contact under FOR FURTHER
INFORMATION CONTACT.
Submitting Comments: You may
submit comments by one of the
following methods:
• Internet: https://
www.regulations.gov. Search for and
submit comments on FWS–R7–ES–
2024–0128.
• U.S. mail: Public Comments
Processing, Attn: Docket No. FWS–R7–
ES–2024–0128, U.S. Fish and Wildlife
Service, MS: PRB (JAO/3W), 5275
Leesburg Pike, Falls Church, VA 22041–
3803.
We request that you send comments
only by one of the methods described
above. We will post all comments at
https://www.regulations.gov. You may
request that we withhold personal
identifying information from public
review; however, we cannot guarantee
that we will be able to do so. For more
information, see Public Comment
Procedures under SUPPLEMENTARY
INFORMATION.
FOR FURTHER INFORMATION CONTACT:
Charles Hamilton, Marine Mammals
Management, by telephone at 907–786–
3800; by email at FW7_ak_marine_
mammals@fws.gov; or by mail at U.S.
Fish and Wildlife Service, MS–341,
1011 East Tudor Road, Anchorage, AK
99503. Individuals in the United States
who are deaf, deafblind, hard of hearing,
or have a speech disability may dial 711
(TTY, TDD, or TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUMMARY:
E:\FR\FM\02JAN1.SGM
02JAN1
]]>Agencies
[Federal Register Volume 90, Number 1 (Thursday, January 2, 2025)]
[Notices]
[Pages 113-114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Integrative Health Special Emphasis Panel; Institutional Research
Training Grants (IT).
Date: January 21, 2025.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Center for Complementary and Integrative,
Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Michael E Authement, Ph.D., Scientific Review
Officer, Office of Scientific Review, Division of Extramural
Activities, 6707 Democracy Boulevard, Bethesda, MD 20817,
[email protected].
[[Page 114]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 27, 2024.
David W Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-31477 Filed 12-31-24; 8:45 am]
BILLING CODE 4140-01-P
